ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcome Implications of Benzodiazepines and Opioid Co-Prescriptions before Kidney Transplantation

N. Lam,1 M. Schnitzler,2 D. Axelrod,3 V. Dharnidharka,4 D. Segev,5 A. Naik,6 H. Xiao,2 R. Ouseph,2 H. Randall,2 G. Hess,7 B. Kasiske,8 D. Brennan,5 T. Alhamad,4 K. Lentine.2

1Univ Alberta, Edmonton, Canada
2Saint Louis Univ, St. Louis
3Lahey Clinic, Burlington
4Washington Univ, St. Louis
5Johns Hopkins, Baltimore
6Univ Michigan, Ann Arbor
7Hennepin, Minneapolis
8Symphony Health, Conshohocken.

Meeting: 2018 American Transplant Congress

Abstract number: 126

Keywords: Kidney transplantation, Mortality, Outcome, Risk factors

Session Information

Session Name: Concurrent Session: Kidney Psychosocial - 1

Session Type: Concurrent Session

Date: Sunday, June 3, 2018

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 210

Recent studies have identified co-prescription of benzodiazepines and opioids as a risk factor for adverse outcomes in the general population. We previously described associations of opioid use before kidney transplantation (KTx) with mortality after KTx, but the implications of benzodiazepine use in the KTx population have not been described.

We examined a novel linkage of SRTR registry data with records from a pharmaceutical claims warehouse (2008-2015) to characterize benzodiazepine and opioid use in the yr before KTx and associations (adjusted hazard ratio, 95% LCLaHR95% UCL) with death over 1yr post-KTx.

Among 75,430 KTx recipients with available medication data in the year prior to transplant, 7.3% & 43.1% filled a prescription for a benzodiazepine or opioid in the year prior to transplant. Use of both medications was more common among recipients who were white, unemployed, and previous KTx recipients. Benzodiazepine use rose with higher opioid use, from 3.2% among opioid non-uses to 10.2% among those with the highest level opioid use. (Fig 1).

Compared to non-users, high-level pre-transplant benzodiazepine use was associated with 51% (aHR 1.141.511.99) increased risk of death in the year following transplant. Opioid use bore a strong graded relationship with post-KTx survival, and prognostic impact high pre-KTx benzodiazepines was preserved after adjustment for opioids (aHR 1.041.371.83), although an interaction was not present (Fig 2).

Benzodiazepines use is correlated with opioiid use before KTx, and use of these agents have additive associations with post-KTx mortality. Future research is needed to define mechanisms of these associations and the impact of reducing co-prescription on improving outcomes after KTx.

CITATION INFORMATION: Lam N., Schnitzler M., Axelrod D., Dharnidharka V., Segev D., Naik A., Xiao H., Ouseph R., Randall H., Hess G., Kasiske B., Brennan D., Alhamad T., Lentine K. Outcome Implications of Benzodiazepines and Opioid Co-Prescriptions before Kidney Transplantation Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lam N, Schnitzler M, Axelrod D, Dharnidharka V, Segev D, Naik A, Xiao H, Ouseph R, Randall H, Hess G, Kasiske B, Brennan D, Alhamad T, Lentine K. Outcome Implications of Benzodiazepines and Opioid Co-Prescriptions before Kidney Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/outcome-implications-of-benzodiazepines-and-opioid-co-prescriptions-before-kidney-transplantation/. Accessed May 13, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences